Related Experiment Video
Updated: May 16, 2026
08:02
Establishment of a Minimally Invasive Rat Model of Pulmonary Embolism Using Autologous Blood Clots
Published on: October 25, 2024
Predicting short-term mortality in patients with pulmonary embolism: a simple model
Andriana I Papaioannou1, Alcibiades Kastanis, Foteini Malli
1Department of Respiratory Medicine, School of Medicine, University of Thessaly, Larissa, Greece.
The American Journal of the Medical Sciences
|November 29, 2012
Summary
A new prognostic score using age, Charlson index, and alveolar-arterial gradient can identify patients with pulmonary embolism (PE) at high risk of 30-day mortality.
Area of Science:
- Pulmonary Medicine
- Cardiology
- Critical Care
Background:
- Pulmonary embolism (PE) poses a significant risk of mortality.
- Accurate risk stratification is crucial for managing PE patients.
- Existing prognostic models may require complex data.
Purpose of the Study:
- To develop a straightforward prognostic rule for classifying PE patients by 30-day mortality risk.
- To identify key clinical and laboratory variables associated with PE mortality.
Main Methods:
- Enrolled 100 patients diagnosed with PE.
- Recorded clinical and laboratory findings on admission.
- Analyzed survival data to determine predictors of 30-day mortality.
Main Results:
- Age, Charlson index, and alveolar-arterial (A-a) gradient were significant predictors of mortality.
- A prognostic score was developed using cut-off values: age >67 years, A-a gradient >52.8 mm Hg, Charlson index >2.
- The score demonstrated validation in a separate cohort of 30 PE patients.
Conclusions:
- A simple, validated score using routine variables can stratify PE patients into risk categories for 30-day mortality.
- This prognostic model aids in clinical decision-making for PE management.
- Further validation in larger cohorts is recommended.
Related Concept Videos
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:15Assumptions of Survival Analysis
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
01:26Pharmacokinetic Models: Comparison and Selection Criterion
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.